Sign in

CIK 0001681087 · Non-accelerated filer<br>Smaller reporting company

Tectonic Therapeutic, Inc.

Sign in to watch
Ticker
TECX
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
NY
Entity type
operating
EIN
810710585
Phone
(339) 666-3320
Business address
490 ARSENAL WAY, SUITE 200, WATERTOWN, MA
Former names
AvroBio, Inc., AVROBIO, Inc.
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$13,920
in 2 filings, $14K under 10b5-1 plans

Net −$13,920. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Pace of trading Bought Sold

Who's trading

90 days

  1. McNamara Peter −$14K Chief Scientific Officer sold 1% of stake

Reading 86 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2024-05-13 Leonard Braden Michael 10% owner Purchase +216,053 $1.26 $272K 4,471,380
2024-02-05 Golipour Azadeh Chief Technology Officer Shares withheld for taxes −12,232 $1.20 $15K 55,872
2024-02-05 Ridha Essra Chief Medical Officer Shares withheld for taxes −16,953 $1.20 $20K 15,881
2024-02-05 Ostrowski Erik Interim CEO, President and CFO Shares withheld for taxes −13,099 $1.20 $16K 29,285
2024-02-05 Avruch Steven Chief Legal Officer Shares withheld for taxes −10,812 $1.20 $13K 22,022
2024-02-01 Golipour Azadeh Chief Technology Officer Option exercise +37,334 68,104
2024-02-01 Golipour Azadeh Chief Technology Officer Option exercise · Restricted Stock Unit −37,334 111,999
2024-02-01 Ridha Essra Chief Medical Officer Option exercise +32,834 32,834
2024-02-01 Ridha Essra Chief Medical Officer Option exercise · Restricted Stock Unit −32,834 98,499
2024-02-01 Ostrowski Erik Interim CEO, President and CFO Option exercise +40,084 42,384
2024-02-01 Ostrowski Erik Interim CEO, President and CFO Option exercise · Restricted Stock Unit −40,084 120,249
2024-02-01 Avruch Steven Chief Legal Officer Option exercise +32,834 32,834
2024-02-01 Avruch Steven Chief Legal Officer Option exercise · Restricted Stock Unit −32,834 98,499
2023-07-01 Ostrowski Erik Interim CEO, President and CFO Grant or award · Restricted Stock Unit +70,000 70,000
2023-06-12 Golipour Azadeh Chief Technology Officer Shares withheld for taxes −5,463 $1.19 $7K 30,881
2023-06-12 Golipour Azadeh Chief Technology Officer Shares withheld for taxes −111 $1.21 $134 30,770
2023-06-06 PAIGE CHRISTOPHER Director Grant or award · Stock Option (Right to Buy) +17,643 17,643
2023-06-06 Donenberg Phillip B. Director Grant or award · Stock Option (Right to Buy) +17,643 17,643
2023-06-06 Vickers Philip J. Director Grant or award · Stock Option (Right to Buy) +17,643 17,643
2023-06-06 Farfel Gail M Director Grant or award · Stock Option (Right to Buy) +17,643 17,643

Page 9 of 10 · 188 trades